These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 37636690
1. Effects of Chemoradiation Therapy on Hearing in Patients with Malignancy of Head and Neck. Yadav S, Patni D, Munjal VR. Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):1950-1953. PubMed ID: 37636690 [Abstract] [Full Text] [Related]
2. Effects of Chemoradiation on Hearing in Patients with Head and Neck Malignancies: Experience at a Tertiary Referral Care Hospital. Jain A, Banerjee PK, Manjunath D. Indian J Otolaryngol Head Neck Surg; 2016 Dec; 68(4):456-461. PubMed ID: 27833872 [Abstract] [Full Text] [Related]
3. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients. Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S. J Cancer Res Ther; 2020 Dec; 16(3):539-545. PubMed ID: 32719264 [Abstract] [Full Text] [Related]
4. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy. Cheraghi S, Nikoofar P, Fadavi P, Bakhshandeh M, Khoie S, Gharehbagh EJ, Farahani S, Mohebbi A, Vasheghani M, Zare M, Nikoofar A, Mahdavi SR. Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124 [Abstract] [Full Text] [Related]
5. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin. Yip PL, Mok KCJ, Ho HS, Lee WYV, Wong ACL, Lau CT, Wong FCS, Yeung KW, Lee SF. Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581 [Abstract] [Full Text] [Related]
6. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819 [Abstract] [Full Text] [Related]
7. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A. Acta Otolaryngol; 2021 Sep 01; 141(9):885-893. PubMed ID: 34486907 [Abstract] [Full Text] [Related]
8. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study. Apoorva KV, Vijendra Shenoy S, Athiyamaan MS, Kabekkodu S, Kshithi K, Zuturu N. Am J Otolaryngol; 2023 Sep 01; 44(4):103914. PubMed ID: 37178536 [Abstract] [Full Text] [Related]
9. Risk Profiles for Sensorineural Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin-based Chemoradiation. Shorter P, Harden F, Owen R, Panizza B, Burmeister B, Sommerville J, Mengersen K, Foote M. J Med Imaging Radiat Sci; 2017 Mar 01; 48(1):61-67. PubMed ID: 31047212 [Abstract] [Full Text] [Related]
10. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1393-402. PubMed ID: 15817342 [Abstract] [Full Text] [Related]
11. Factors Affecting Permanent Sensorineural Hearing Loss and Bone Conduction in Patients After Receiving Radiotherapy to the Head and Neck Region. Yücel B, Erdiş E, Bahar S, Akkaş Atasever E, Celasun MG, Altuntaş EE. Turk Arch Otorhinolaryngol; 2022 Dec 01; 60(4):212-219. PubMed ID: 37456600 [Abstract] [Full Text] [Related]
12. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Laryngoscope; 2007 Jan 01; 117(1):3-15. PubMed ID: 17202923 [Abstract] [Full Text] [Related]
13. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity? Schultz C, Pecora Liberman PH, Schmidt Goffi-Gomez MV. Audiol Neurootol; 2019 Jan 01; 24(5):253-257. PubMed ID: 31661686 [Abstract] [Full Text] [Related]
14. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL. Cancer; 2006 Feb 15; 106(4):820-9. PubMed ID: 16421885 [Abstract] [Full Text] [Related]
15. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Timmer FC, Hanssens PE, van Haren AE, Mulder JJ, Cremers CW, Beynon AJ, van Overbeeke JJ, Graamans K. Laryngoscope; 2009 Jun 15; 119(6):1076-81. PubMed ID: 19399836 [Abstract] [Full Text] [Related]
16. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy. Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ. JAMA Otolaryngol Head Neck Surg; 2015 Sep 15; 141(9):810-5. PubMed ID: 26291150 [Abstract] [Full Text] [Related]
17. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma. Zhu W, Chen F, Li J, Wang W, Zhang H, Yang G, Zou L, Zhu Y, Yuan W, Ding H, Song X, Wang S. Acta Otolaryngol; 2019 Mar 15; 139(3):263-268. PubMed ID: 30870056 [Abstract] [Full Text] [Related]
18. Otitis media with effusion in children: Cross-frequency correlation in pure tone audiometry. Chow AHC, Cai T, McPherson B, Yang F. PLoS One; 2019 Mar 15; 14(8):e0221405. PubMed ID: 31437206 [Abstract] [Full Text] [Related]
19. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer. Schuette A, Lander DP, Kallogjeri D, Collopy C, Goddu S, Wildes TM, Daly M, Piccirillo JF. JAMA Otolaryngol Head Neck Surg; 2020 Feb 01; 146(2):106-112. PubMed ID: 31750863 [Abstract] [Full Text] [Related]
20. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose. Lasak JM, Klish D, Kryzer TC, Hearn C, Gorecki JP, Rine GP. Otol Neurotol; 2008 Dec 01; 29(8):1179-86. PubMed ID: 18931646 [Abstract] [Full Text] [Related] Page: [Next] [New Search]